Article Details
Retrieved on: 2024-04-27 19:19:07
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Pfizer's genetic therapy targets hemophilia B, the second most common form of the condition, which primarily affects males. More than 38,000 people ...
Article found on: today.rtl.lu
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here